Saudi Arabia Diabetes Market

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology 
3   Executive Summary
4   Introduction
    4.1 Overview
    4.2 Key Industry Trends
5   Diabetes Disease Overview
    5.1 What is Diabetes?
    5.2 Diabetes Diagnosis and Treatment
        5.2.1 Diagnosis
        5.2.2 Treatment
    5.3 Diabetes Complications
6   Saudi Arabia Diabetes Epidemiology
    6.1 Diabetes Population and Prevalence Rates
    6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    6.3 Population and Prevalence Rates by Region
    6.4 Population and Prevalence Rates by Gender
    6.5 Population and Prevalence Rates by Age Group
7   Saudi Arabia Diabetes Market
    7.1 Market Overview
    7.2 Market Performance 
    7.3 Impact of COVID-19
    7.4 Market Forecast
    7.5 SWOT Analysis
        7.5.1 Overview
        7.5.2 Strengths
        7.5.3 Weaknesses
        7.5.4 Opportunities
        7.5.5 Threats
    7.6 Value Chain Analysis
    7.7 Porter’s Five Forces Analysis
        7.7.1 Overview
        7.7.2 Bargaining Power of Buyers
        7.7.3 Bargaining Power of Suppliers
        7.7.4 Degree of Competition
        7.7.5 Threat of New Entrants
        7.7.6 Threat of Substitutes
     7.8 Market Breakup by Segment
        7.8.1 Saudi Arabia Oral Antidiabetics Market
            7.8.1.1 Historical Market Trends
            7.8.1.2 Market Breakup by Class
            7.8.1.3 Market Shares of Key Players
            7.8.1.4 Market Forecast
        7.8.2 Saudi Arabia Insulin Market
            7.8.2.1 Historical Market Trends
            7.8.2.2 Market Breakup by Class
            7.8.2.3 Market Shares of Key Players
            7.8.2.4 Market Forecast
8   Competitive Landscape
    8.1 Competitive Structure
    8.2 Profiles of Key Players 

List of Figures

Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2021 & 2027
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Saudi Arabia: Total Number of Diabetes Patients (in 000), 2016-2021
Figure 6: Saudi Arabia: Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 7: Saudi Arabia (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2016-2021
Figure 8: Saudi Arabia (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 9: Saudi Arabia (Urban & Rural): Total Number of Diabetes Patients (in 000), 2016-2021
Figure 10: Saudi Arabia (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 11: Saudi Arabia (Male & Female): Total Number of Diabetes Patients (in 000), 2016-2021
Figure 12: Saudi Arabia (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 13: Saudi Arabia: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, - in 000), 2016-2021
Figure 14: Saudi Arabia: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, - in 000), 2022-2027
Figure 15: Saudi Arabia: Diabetes Drug Industry Overview
Figure 16: Saudi Arabia: Diabetes Drug Market: Sales Value (in Million US$), 2016-2021
Figure 17: Saudi Arabia: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Saudi Arabia: Diabetes Drug Market: SWOT Analysis
Figure 19: Saudi Arabia: Diabetes Drug Market: Value Chain Analysis
Figure 20: Saudi Arabia: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Saudi Arabia: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2016-2021
Figure 22: Saudi Arabia: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2022-2027
Figure 23: Saudi Arabia: Oral Antidiabetics Market: Sales Value (in Million US$), 2016-2021
Figure 24: Saudi Arabia: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2021
Figure 25: Saudi Arabia: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Saudi Arabia: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Saudi Arabia: Insulin Market: Sales Value (in Million US$), 2016-2021
Figure 28: Saudi Arabia: Breakup of Insulin Market by Class (in %), 2016 & 2021
Figure 29: Saudi Arabia: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Saudi Arabia: Insulin Market Forecast: Sales Value (in Million US$), 2022-2027

List of Tables

Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2021 & 2027
Table 3: Saudi Arabia: Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 4: Saudi Arabia (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 5: Saudi Arabia (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 6: Saudi Arabia (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 7: Saudi Arabia: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2011, 2019 & 2025
Table 8: Saudi Arabia: Diabetes Drug Market: Competitive Structure